ES406590A1 - Procedimiento para la vacunacion preventiva contra viruela. - Google Patents

Procedimiento para la vacunacion preventiva contra viruela.

Info

Publication number
ES406590A1
ES406590A1 ES406590A ES406590A ES406590A1 ES 406590 A1 ES406590 A1 ES 406590A1 ES 406590 A ES406590 A ES 406590A ES 406590 A ES406590 A ES 406590A ES 406590 A1 ES406590 A1 ES 406590A1
Authority
ES
Spain
Prior art keywords
contg
vaccinia virus
attenuated vaccinia
smallpox vaccine
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES406590A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BAYERN FREISTAAT
Original Assignee
BAYERN FREISTAAT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712145477 external-priority patent/DE2145477C3/de
Application filed by BAYERN FREISTAAT filed Critical BAYERN FREISTAAT
Publication of ES406590A1 publication Critical patent/ES406590A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES406590A 1971-09-11 1972-09-11 Procedimiento para la vacunacion preventiva contra viruela. Expired ES406590A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712145477 DE2145477C3 (de) 1971-09-11 Impfstoff für die intracutane Pockenschutzimpfung

Publications (1)

Publication Number Publication Date
ES406590A1 true ES406590A1 (es) 1975-09-16

Family

ID=5819271

Family Applications (1)

Application Number Title Priority Date Filing Date
ES406590A Expired ES406590A1 (es) 1971-09-11 1972-09-11 Procedimiento para la vacunacion preventiva contra viruela.

Country Status (5)

Country Link
AT (1) AT320149B (enExample)
BE (1) BE787901A (enExample)
CH (1) CH568392A5 (enExample)
DK (1) DK137392C (enExample)
ES (1) ES406590A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
WO2004015118A1 (en) 2002-08-07 2004-02-19 Bavarian Nordic A/S Vaccinia virus host range genes to increase the titer of avipoxviruses
WO2004087201A2 (en) 2003-03-28 2004-10-14 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mva virus expressing modified hiv envelope, gag, and pol genes
WO2006026667A2 (en) 2004-08-27 2006-03-09 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant mva viruses expressing glade a/g, clade b, and clade c modified hiv, gag and pol genes
AU2008250596C1 (en) 2007-05-14 2010-11-25 Bavarian Nordic A/S Purification of Vaccinia virus- and recombinant Vaccinia virus-based vaccines
JP2013507107A (ja) 2009-10-08 2013-03-04 バヴァリアン・ノルディック・アクティーゼルスカブ Ｈｉｖに対するヒトにおける広範なｔ細胞応答の生成
CA2802430C (en) 2010-07-20 2021-07-20 Bavarian Nordic A/S Method for harvesting poxvirus
EP2620446A1 (en) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
DE102013004595A1 (de) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV-Impfstoffe
CN109071592B (zh) 2016-01-08 2022-07-19 吉奥瓦科斯公司 用于产生对肿瘤相关抗原的免疫应答的组合物和方法
CN113924114A (zh) 2019-05-22 2022-01-11 吉利德科学公司 Tlr7调节化合物和hiv疫苗的组合
AU2020384323A1 (en) 2019-11-14 2022-06-02 Aelix Therapeutics, S.L. Dosage regimens for vaccines
CA3167052A1 (en) 2020-02-14 2021-08-19 Mary Jo Hauser Vaccines and uses thereof to induce an immune response to sars-cov2
WO2021260065A1 (en) 2020-06-24 2021-12-30 Consejo Superior De Investigaciones Científicas (Csic) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP3928789A1 (en) 2020-06-24 2021-12-29 Consejo Superior de Investigaciones Científicas (CSIC) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP4108257A1 (en) 2021-06-23 2022-12-28 Consejo Superior De Investigaciones Científicas Mva-based vaccine against covid-19 expressing a prefusion-stabilized sars-cov-2 s protein
WO2022269003A1 (en) 2021-06-23 2022-12-29 Consejo Superior De Investigaciones Cientificas MVA-BASED VACCINE EXPRESSING A PREFUSION-STABILIZED SARS-CoV-2 S PROTEIN

Also Published As

Publication number Publication date
DE2145477B2 (de) 1976-04-01
DE2145477A1 (de) 1973-03-15
DK137392B (da) 1978-02-27
DK137392C (da) 1978-09-18
CH568392A5 (enExample) 1975-10-31
AT320149B (de) 1975-01-27
BE787901A (fr) 1972-12-18

Similar Documents

Publication Publication Date Title
GB1007347A (en) Preparation of optically active lactides
WO1980002504A1 (en) Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
AU3475271A (en) Face steamer
CA924330A (en) High purity hot pressed boron nitride
RO68219A (ro) Procedeu pentru prepararea de 4-amino-3,5-dihalogen-fenil-etanolamine
CA970110A (en) Low-froth, water-soluble dyeing auxiliaries
CA956130A (en) Steam pressure cooker
ZA715992B (en) Low-froth,water-soluble dyeing auxiliaries
NO137598C (no) Fremgangsmaate til fremstilling av ren, krystallinsk penicillinacylase
NL163214C (nl) Werkwijze om 2,4-diamino-5-benzylpyrimidinen te bereiden.
CA963000A (en) 15.alpha.,16.alpha.-METHYLENE-STEROIDS
AU461179B2 (en) Steam chamber
CA1007567A (en) Vaccine adjuvants
AU449601B2 (en) Bis-(aminoalkylsulfamoyl) anthraquinones
AU3252271A (en) Vaccine preparation
AU447269B2 (en) Steam boilers
AU476149B2 (en) Process for preparing live virus vaccines
CA943458A (en) Process for producing anhydrous smallpox vaccine
CA982123A (en) 1,5-and 1,8-dihydroxy=anthraquinones
DK133243C (da) 2,4-diamino-5-benzyl-6-thiopyrimidiner til anvendelse som mellemprodukter og fremgangsmade til deres fremstilling
Ohmura et al. 91Zr (p, t) 89Zr Reaction at 51.7 MeV
CA875366A (en) Steam cooled gas turbine
MATSUURA et al. Utilization of Carbonized Rice Hull as a Medium for Growing Small Rice Seedling for Transplanter
CA875583A (en) Preparation for optically active 3,4-dihydroxyphenyl-alanine
CA866998A (en) Integral vapor generator-nuclear reactor